SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending as traders discuss its potential for a significant breakout, drawing comparisons to other Hong Kong-based stocks with crypto tie-ins that have recently seen substantial gains. Community members are closely watching the low float and anticipating news, particularly regarding the company's previously announced plans for a crypto treasury. Bullish investors hope CLIK can mirror the success of similar plays, while others express concerns about its ability to execute and sustain momentum.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending amid discussions around Amazon's competitive moves and their potential impact on the ad-tech landscape; the community is debating the validity of recent reports and the company's long-term prospects in light of these challenges. Some investors view the dip as a buying opportunity, while others express concern over the stock's performance and potential market manipulation. The company's response and upcoming earnings are key points of focus.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase ($COIN) is trending following an upgrade from J.P. Morgan, with community members discussing potential revenue streams and the Base blockchain's future. Bullish traders anticipate a run-up to earnings, while others express concern over crypto market volatility and its impact on the stock. Some investors mention holding their Bitcoin on Coinbase, emphasizing the importance of prediction markets/US equities being added to the platform.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as investors assess its recent earnings beat and future guidance, with some analysts predicting multiple price target raises. Community members are actively discussing the company's strong brands and potential for long-term growth, as well as concerns about tariff headwinds and the impact of a potential CEO change. Despite these challenges, many see $PG as a reliable defensive stock, especially as it approaches its ex-dividend date.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending with increased after-hours activity and high trading volume as the community debates whether a large drop in price creates a buying opportunity. Community members are analyzing the company's recent statement addressing stock volatility and are discussing potential dilution impacts, as well as its long-term value. Some traders point to technical indicators suggesting a potential rebound, while others caution against a possible pump-and-dump scenario.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft ($MSFT) is trending as investors analyze the potential impact of strong Azure cloud growth and AI integrations on upcoming earnings. The community is actively discussing technical indicators, revised price targets, and potential breakout points, with some noting institutional accumulation patterns. Sentiment seems cautiously optimistic, with many looking for confirmation of continued cloud momentum and AI adoption rates in the earnings report.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a significant surge, with the community citing recent insider buying activity as a possible catalyst. Discussions also mention a milestone payment from Merck related to their Alzheimer's program. Some traders are closely watching the low float and suggesting a potential short squeeze, while others express caution due to potential dilution.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending as investors discuss upcoming Phase 3 results and the potential of new drugs in its portfolio, with readouts anticipated before Thanksgiving. Community members are also weighing the long-term potential of the stock, considering its current market cap and future growth prospects. Bullish sentiment is fueled by the protective hedging strategy and possible new drug additions, while others are eyeing call options.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to an FDA investigation into increased reports of allergic reactions to specific lots of intravenous immunoglobulin (IGIV) products, including two ADMA lots, leading to a voluntary recall. While some community members view this as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run-up, others are concerned about potential impacts on future earnings and are closely watching for management's response and share buyback activity. The community is also discussing the broader context of hypersensitivity reactions to IGIV drugs and ADMA's growth potential within the plasma-derived therapies market.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is gaining attention, with community members promoting it as the next big opportunity. Conversations highlight its availability on Phantom Wallet and its potential for significant gains. The coin is frequently mentioned alongside other popular cryptocurrencies like Bitcoin, Solana, and Shiba Inu.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Glen Echo, MD.

Regenerx Biopharmaceuticals

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

RGRX
Regenerx Biopharmaceuticals

Feed

News

Sentiment

Fundamentals

Info

Latest RGRX News

RGRXRegenerx Biopharmaceuticals